Hepatocyte Heparan Sulfate Is Required for Adeno-Associated Virus 2 but Dispensable for Adenovirus 5 Liver Transduction In Vivo.

Saved in:
Bibliographic Details
Title: Hepatocyte Heparan Sulfate Is Required for Adeno-Associated Virus 2 but Dispensable for Adenovirus 5 Liver Transduction In Vivo.
Authors: Zaiss AK; Department of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA., Foley EM; Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, California, USA., Lawrence R; Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, California, USA., Schneider LS; Department of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA., Hoveida H; Department of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA., Secrest P; Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, California, USA., Catapang AB; Department of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA., Yamaguchi Y; Sanford-Burnham Medical Research Institute, La Jolla, California, USA., Alemany R; Translational Research Laboratory, IDIBELL-Institut Catala d'Oncologia, Barcelona, Spain., Shayakhmetov DM; Department of Pediatrics and Medicine, Emory University, Atlanta, Georgia, USA., Esko JD; Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, California, USA., Herschman HR; Department of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA hherschman@mednet.ucla.edu.
Source: Journal of virology [J Virol] 2015 Oct 21; Vol. 90 (1), pp. 412-20. Date of Electronic Publication: 2015 Oct 21 (Print Publication: 2016).
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society For Microbiology Country of Publication: United States NLM ID: 0113724 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1098-5514 (Electronic) Linking ISSN: 0022538X NLM ISO Abbreviation: J Virol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1098-5514
DOI:10.1128/JVI.01939-15